Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Other Non-Current Liabilities (2020)

Cogent Biosciences has reported Other Non-Current Liabilities over the past 1 years, most recently at $5.5 million for Q4 2020.

  • Quarterly results put Other Non-Current Liabilities at $5.5 million for Q4 2020, changed N/A from a year ago — trailing twelve months through Dec 2020 was $5.5 million (changed N/A YoY), and the annual figure for FY2020 was $5.5 million, changed.
  • Other Non-Current Liabilities for Q4 2020 was $5.5 million at Cogent Biosciences.
  • Over the last five years, Other Non-Current Liabilities for COGT hit a ceiling of $5.5 million in Q4 2020 and a floor of $5.5 million in Q4 2020.